HomeEXECUTIVES
EXECUTIVES
The medical device news magazine is the latest source for industry scoop. In this article, we take a look at which executives are on the move.
As the medical device industry rapidly expands, so does the need for executive leadership. Recently, several top executives have made moves within the industry. Some have taken new positions at other companies, while others have started their own businesses. Here’s a look at who’s been making headlines lately.
EarlySense Names John Dragovits as New SVP of Strategic Partnerships
John Dragovits has more than 30 years of experience as a healthcare and healthcare IT executive leader..
Dr Edward Evantash Appointed CMO of Alydia Health
Dr Edward Evantash joins Alydia from Hologic, a global leader in women’s healthcare technology.
Kenny Gardner Named Chief People Officer at DaVita Kidney Care
Kenny Gardner has been with DaVita for nearly a decade and most recently served the company as a group vice president (GVP), overseeing field operations in the Southeast U.S.
Edward C. Jauch, M.D. Appointed Chairman of Ischemia Care Clinical Advisory Board
The Ischemia Care clinical advisory board will guide Ischemia Care’s mission to empower clinicians with biological insights that minimize unnecessary invasive testing and raise diagnostic certainty for maximum treatment benefit.
Philippe Menu, MD-PhD, MBA Appointed CMO at SOPHiA GENETICS
Dr. Philippe Menu spent the last 8 years at McKinsey & Company where he co-led the McKinsey Cancer Center & served dozens of clients in the biopharma sector.
Scott Trevino Promoted to Senior VP Product Management and Solutions at TRIMEDX
Scott Trevino will partner across the organization to develop, drive and execute the product strategy for TRIMEDX’s technology and analytics portfolio.
Glooko Appoints Komathi Stem as COO
Komathi Stem will have global responsibility for Glooko product development, clinical research, and customer support.
Zach Henderson Named CCO of Glooko
Zach Henderson will have global responsibility for all commercial efforts, including the company's work with its key strategic partners' revenue generation initiatives.
Jim Schuermann Appointed Independent Director at CorWave
Jim Schuermann was instrumental in transforming HeartWare, an LVAD start-up valued around $100M when he joined, into a $1+Bn Nasdaq-listed company.